Systematic review of the neurobiological relevance of chemokines to psychiatric disorders

Stuart, Michael J., Singhal, Gaurav and Baune, Bernhard T. (2015) Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Frontiers in Cellular Neuroscience, 9 September: 357.1-357.15. doi:10.3389/fncel.2015.00357

Author Stuart, Michael J.
Singhal, Gaurav
Baune, Bernhard T.
Title Systematic review of the neurobiological relevance of chemokines to psychiatric disorders
Journal name Frontiers in Cellular Neuroscience   Check publisher's open access policy
ISSN 1662-5102
Publication date 2015-09-10
Sub-type Critical review of research, literature review, critical commentary
DOI 10.3389/fncel.2015.00357
Open Access Status DOI
Volume 9
Issue September
Start page 357.1
End page 357.15
Total pages 15
Place of publication Lausanne, Switzerland
Publisher Frontiers Research Foundation
Language eng
Abstract Psychiatric disorders are highly prevalent and disabling conditions of increasing public health relevance. Much recent research has focused on the role of cytokines in the pathophysiology of psychiatric disorders; however, the related family of immune proteins designated chemokines has been relatively neglected. Chemokines were originally identified as having chemotactic function on immune cells; however, recent evidence has begun to elucidate novel, brain-specific functions of these proteins of relevance to the mechanisms of psychiatric disorders. A systematic review of both human and animal literature in the PubMed and Google Scholar databases was undertaken. After application of all inclusion and exclusion criteria, 157 references were remained for the review. Some early mechanistic evidence does associate select chemokines with the neurobiological processes, including neurogenesis, modulation of the neuroinflammatory response, regulation of the hypothalamus–pituitary–adrenal axis, and modulation of neurotransmitter systems. This early evidence however does not clearly demonstrate any specificity for a certain psychiatric disorder, but is primarily relevant to mechanisms which are shared across disorders. Notable exceptions include CCL11 that has recently been shown to impair hippocampal function in aging – of distinct relevance to Alzheimer’s disease and depression in the elderly, and pre-natal exposure to CXCL8 that may disrupt early neurodevelopmental periods predisposing to schizophrenia. Pro-inflammatory chemokines, such as CCL2, CCL7, CCL8, CCL12, and CCL13, have been shown to drive chemotaxis of pro-inflammatory cells to the inflamed or injured CNS. Likewise, CX3CL has been implicated in promoting glial cells activation, pro-inflammatory cytokines secretion, expression of ICAM-1, and recruitment of CD4+ T-cells into the CNS during neuroinflammatory processes. With further translational research, chemokines may present novel diagnostic and/or therapeutic targets in psychiatric disorders.
Keyword Depression
Alzheimer's disease
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: Official 2016 Collection
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 29 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 30 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 04 Oct 2015, 10:24:29 EST by System User on behalf of Scholarly Communication and Digitisation Service